06.11.2024 17:40:00

Neurones: Organic growth up 10.5% in 3rd quarter 2024

PRESS INFORMATION
Heading: 3rd quarter 2024 revenues        Nanterre, November 6, 2024 (after trading)

Organic growth up 10.5% in 3rd quarter 2024

(not audited, in millions of euros)20232024growthof which organic
3rd quarter revenues177196.7+ 11.1%+ 10.5%
Total as at the end-September545.7599.1+ 9.8%+ 8.9%

Achievements

NEURONES posted double-digit organic growth in the 3rd quarter.

The most notable advances continue to be in Data, Digital Projects, Cybersecurity, Sovereign and Secure Cloud (SecNumCloud).

Total turnover is down 3 points (14.3% vs. 17.3% a year ago).

Over the entire nine-month period, operating profit * amounted to 9.6% of revenues.

Outlook

For 2024, NEURONES confirms its forecasts made at the beginning of the year (around €800 million in revenues and 9.5% in operating profit).

* not audited and after inclusion of 0.8% of expenses related to bonus shares.

About NEURONES
With 7,100 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – DSS mid-caps – ‘PEA-PME’ eligible
www.neurones.net

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

jpbrutin@oconnection.fr


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net


Attachment


Nachrichten zu NeuronesAct.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu NeuronesAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

NeuronesAct. 44,00 0,69% NeuronesAct.